Skip to main content
Brain, Behavior, & Immunity - Health logoLink to Brain, Behavior, & Immunity - Health
. 2026 Oct 29;58:101394. doi: 10.1016/j.bbih.2026.101394

Perceived psychological stress, social support, and the incidence of herpes zoster in a cohort study

Kosuke Kawai a,⁎, Elkin V Lemos b, Barbara P Yawn c
PMCID: PMC13744827  PMID: 43001288

Abstract

Background

High psychological stress has commonly been thought to increase the risk of herpes zoster (HZ); however, prior studies have reported conflicting results. We examined the association between perceived psychological stress and the incidence of HZ in a large, cohort study.

Methods

This is a longitudinal cohort study of participants with survey and electronic health records (EHR) data from the All of Us Research Program. Perceived stress was measured using the 10-item Perceived Stress Scale with incident HZ identified from EHR. Multivariable Cox proportional hazards models were used.

Results

Among 99,686 participants, a total of 1122 incident cases of HZ occurred during 230,368 person-years. Perceived stress was not associated with a risk of HZ after adjusting for age, sex, race/ethnicity, comorbidities, and socioeconomic and lifestyle factors (multivariable-adjusted HR comparing the highest vs. the lowest quartile: 1.00; 95% CI: 0.83-1.19). High perceived stress was associated with an increased risk of HZ among participants with low social support (HR: 1.65; 95% CI: 1.03–2.66) but not among participants with medium/high social support (HR: 1.01; 95% CI: 0.82-1.26).

Conclusions

We found no overall association between perceived stress and the risk of HZ. However, in adults with low social support, high perceived stress was associated with a higher risk of HZ.

Keywords: Herpes zoster, Shingles, Varicella-zoster virus, Stress, Social support

Highlights

  • •

    Although commonly stated in medical literature, no clear evidence links stress to shingles.

  • •

    We found no association between perceived psychological stress and the risk of herpes zoster in this large, diverse cohort study.

  • •

    In the subgroup of participants with low social support, high perceived stress was associated with an increased risk of herpes zoster.

1. Introduction

Herpes zoster (HZ), also known as shingles, is a painful, blistering rash caused by the reactivation of the latent varicella-zoster virus (VZV) (Hope-Simpson, 1965; Yawn et al., 2007). One of the serious complications is postherpetic neuralgia (PHN), characterized by pain that may persist for several months or even years (Kawai et al., 2014). PHN can be severely debilitating, significantly impairing patients’ quality of life through physical limitations, emotional distress, and social withdrawal (Johnson et al., 2010). Furthermore, HZ was associated with an increased risk of major adverse cardiovascular events (Curhan et al., 2022; Yawn et al., 2016). Risk factors for HZ include older age and immunocompromising conditions and therapies, including Janus Kinase (JAK) inhibitors, that may impair cell-mediated immunity (McKay et al., 2020; Winthrop et al., 2022). Additionally, a family history of HZ, autoimmune diseases, depression, asthma, diabetes mellitus, and chronic obstructive pulmonary disease may increase risk of HZ (Kawai and Yawn, 2017). In the US, an adjuvanted recombinant zoster vaccine is recommended for adults 50 years of age and older to protect against HZ and its complications (Lal et al., 2015).

High psychological stress has commonly been thought to increase the risk of HZ; however, there is no clear evidence to support this as studies have reported conflicting results (Harpaz et al., 2015; Kawai and Yawn, 2017; Kim and Lee, 2025; Lasserre et al., 2012; Marin et al., 2016; Schmader et al., 1990, 1998; Schmidt et al., 2017, 2021; Takao et al., 2018). Some prior studies have used a case-control design, which may be subject to recall bias, while others assessed perceived stress using a single-item questionnaire, which might oversimplify the construct and lead to misclassification of exposure. Despite these limitations of prior studies, it is plausible that psychological stress may increase the risk of HZ. High psychological stress may dysregulate the hypothalamic–pituitary–adrenal (HPA) axis, leading to elevated cortisol levels and inducing the production of pro-inflammatory cytokines, including IL-6 and TNF-α, which can lead to persistent inflammation and suppress immune function (O'Connor et al., 2021). Depression is associated with chronic, low-grade systemic inflammation and reduced VZV-specific cell-mediated immune response (Irwin et al., 2011). Prior studies have consistently linked depression to an increased risk of HZ (Forbes et al., 2014; Huang et al., 2025; Kawai and Yawn, 2017; Marin et al., 2016). Additionally, other psychological factors reported to be associated with the risk of HZ include mood disorders, post-traumatic stress disorder (PTSD), and sleep disturbances (Huang et al., 2025; Kim and Lee, 2025; Marin et al., 2016; Sinayobye et al., 2015).

Social support plays an important role in mental health and may mediate the relationship between stress and risk of HZ by protecting against psychological stress, mitigating stress-related immune dysregulation and strengthening coping abilities. According to the stress-buffering hypothesis, social support protects against potentially adverse effects of stressful events and may reduce susceptibility to infection (Cohen et al., 2015; Cohen and Wills, 1985; Janicki Deverts et al., 2017). For example, a protective effect of social support on the deleterious effect of stress on infection was reported among cancer patients (Roy et al., 2021). Because no prior studies have investigated the stress-buffering effects of social support on the risk of HZ, we conducted an exploratory analysis to examine this potential buffering effect.

The objective of our study is to examine the association between self-perceived psychological stress and the incidence of HZ in a large cohort study from the All of Us Research Program in the U.S. Specifically, we tested the primary hypothesis that higher perceived stress is prospectively associated with an increased risk of HZ. Our study aimed to improve upon prior research. Self-perceived stress was assessed using the 10-item Perceived Stress Scale (PSS), a reliable and validated instrument. The large cohort allow us to perform subgroup analyses by age group, sex, race and ethnicity, income levels, and social support. We also accounted for a wide range of potential confounding factors, including comorbidities, medications, and vaccines as well as socioeconomic and lifestyle factors. The All of Us cohort is a large on-going study that focuses on enrolling participants from communities that are historically underrepresented in biomedical research. A key strength of our study is the investigation of psychological stress in a large diverse cohort, which is particularly important given that racial and ethnic minority groups and individuals with lower socioeconomic status may experience disproportionately higher levels of stress.

2. Methods

2.1. Study population

The All of Us Research Program is a longitudinal cohort study aimed at accelerating biomedical research and improving health by enrolling more than one million diverse participants across the U.S. (All of Us Research Program et al., 2019). The program collects data from a wide variety of sources, including self-reported surveys, electronic health records (EHRs), physical measurements, and wearable technologies. The All of Us program was approved by the National Institutes of Health Institutional Review Board. All participants provided informed consent to participate in the study, with the protocol approved and actively monitored by the All of Us Research Program Institutional Review Board.

The All of Us Research Program recruits participants through a network of regional medical centers, large integrated healthcare systems, community health centers, and Veterans Affairs medical facilities. The All of Us Research program utilize Observational Medical Outcomes Partnership Common Data Model (OMOP CDM) to standardize electronic health records (EHR) data from more than 50 health care organizations and ensures participant privacy. EHR data from these partner networks include ambulatory, urgent care, specialty, and inpatient encounters, facilitating continuity of clinical data capture across healthcare settings. EHR data include healthcare clinician visits, diagnoses, procedures, medications, and laboratory tests. Recorded data elements are coded as source concepts (including ICD-9 and ICD-10) and mapped to standard Systematized Nomenclature of Medicine Clinical Term (SNOMED CT) codes. All of Us participants completed the Basics and Lifestyle questionnaires at the time of enrollment. They are also invited to take part in additional optional surveys, including the Social Determinants of Health survey. We used Registered Tier Dataset v8, which comprises data from May 30, 2017, to October 1, 2023.

A total of 626,383 participants completed the Basic Survey, and 256,727 participants (41%) completed the Social Determinants of Health (SDOH) survey (Supplementary Fig. 1). Of them, 223,606 participants completed PSS. For the EHR cohort, 369,775 participants consented to data sharing and 283,928 met the inclusion criterion of having at least 1 year of medical records prior to enrollment. We further excluded 1781 participants with diagnosis of HZ in the 1 year prior to the enrollment. Overall, 99,686 participants completed the Basic and SDOH surveys and met EHR eligible criteria, and were included this study.

2.2. Outcome

Incident cases of HZ were identified from EHR data. SNOMED CT codes and their corresponding OMOP concept IDs used for diagnosis are listed in Supplementary document.

2.3. Exposure

The PSS was assessed at enrollment as part of the Social Determinants of Health survey. The PSS-10 is a 10-item questionnaire subjectively measuring how stressed a person has felt over the past month (Cohen et al., 1983; Ezzati et al., 2014). The PSS-10 includes two subscales: perceived helplessness and perceived self-efficacy. The perceived helplessness subscale assesses the extent to which individuals feel overwhelmed, stressed, and lacking control over important aspects of their lives. The perceived self-efficacy subscale reflects the extent to which individuals feel confident in their ability to manage demands, cope with difficulties, and handle unexpected problems. Items are assessed using a five-point Likert scale ranging from 0 (never) to 4 (very often). After reverse scoring four positive items, responses are summed to a total score ranging from 0 to 40, with higher scores indicating higher levels of perceived stress.

The 8-item modified Medical Outcomes Study Social Support Survey (MOS-SS) measures social support from family, friends, and community relationships (Moser et al., 2012). The MOS-SS has two subscales covering two domains: instrumental support, which reflects tangible assistance such as help with meals, transportation, or household chores, and emotional support, which assesses social companionship, empathy, and assistance with problem-solving or decision-making. The 8-item MOS-SS had a high internal consistency and adequate construct validity (Moser et al., 2012). Items are rated on a 5-point Likert scale (ranging from 1 = none of the time to 5 = all of the time). The overall scale is scored by calculating the item average and transforming to a 0 to 100 scale, with higher scores indicating high social support.

2.4. Covariates

We considered various demographic, cultural/contextual, medical, and lifestyle factors that could be potential confounding factors. Self-reported demographic and lifestyle information included age at enrollment, sex at birth (female, male, other), race/ethnicity (non-Hispanic White, non-Hispanic Black, non-Hispanic Asian, Hispanic, other), household income (<$35 K, $35-50 K, $50-75 K, $75-150 K, >$150 K), smoking status (never, former, and current), and body mass index (BMI; underweight, normal, overweight, obese). Based on the prior studies of risk factors for HZ, we selected the following comorbidities as potential confounding factors: cancer other than non-melanoma skin cancers, HIV/AIDs, rheumatoid arthritis, systemic lupus erythematosus, inflammatory bowel disease, chronic kidney disease, diabetes mellitus, asthma, chronic obstructive pulmonary disease, and depression (Kawai and Yawn, 2017). We also included use of corticosteroids (including inhaled corticosteroids), use of JAK inhibitors, live-attenuated zoster vaccine, and adjuvanted recombinant zoster vaccine (Qian et al., 2021; Winthrop et al., 2022; Yawn et al., 2024). Comorbidities and medication/vaccination histories were based on EHR data from the year prior to enrollment.

2.5. Statistical methods

The participants’ PSS scores were categorized into quartiles based on their distribution (0-7, 8-12, 13-18, and 19-40). The MOS-SS were also categorized into quartiles (0-55, 56-77, 78-95, 96-100). Participants contributed person-time from the date of enrollment until the first diagnosis of herpes zoster or the end of follow up. Multivariable Cox proportional hazards models were built to examine the association between PSS and risk of HZ after adjusting for demographic, medical, and lifestyle factors. A linear trend was examined by modeling the median value of each PSS category as a continuous variable. We also used the restricted cubic splines, which provide flexible smooth curves, to evaluate the non-linear association between PSS and risk of HZ. We conducted subgroup analyses by reported social support, age group, sex, race/ethnicity, and household income. We have performed sensitivity analysis where we restricted the follow up period to 1 year after the assessment of PSS. All analyses were conducted in the All of Us Research Workbench in SAS and R version 4.5.0.

3. Results

A total of 99,686 participants were included (Table 1). The mean age was 55.5 (SD 15.7) years. The mean PSS score was 13.7 (SD 7.8) and the mean MOS social support score was 73.2 (SD 25.4). A total of 1122 incident cases of HZ (1.1%) occurred among 99,686 participants during a mean follow-up of 2.3 years (SD 1.8). A total of 1122 incident cases of HZ during 230,368 person-years of follow-up corresponds to an incidence rate of 4.9 cases per 1000 person-years. The mean PSS was 13.6 (SD 7.9) among patients with HZ and 13.7 (SD 7.8) among patients without HZ. The mean MOS-SS was 72.4 (SD 25.3) among patients with HZ and 73.2 (SD 25.4) among those without HZ.

Table 1.

Baseline characteristics of 99,686 participants from the All of Us Research Program.

N (%)
Age, years, mean (SD) 55.5 (15.7)
Sex
 Female 64845 (65.1%)
 Male 34181 (34.3%)
 Other 660 (0.6%)
Race/ethnicity
 Hispanic 10035 (10.1%)
 Non-Hispanic White 73739 (73.0%)
 Non-Hispanic Black 8098 (8.1%)
 Non-Hispanic Asian 2244 (2.2%)
 Others 6570 (6.6%)
Annual household income ($)
 < 50000 28298 (28.4%)
 ≥ 50000 60159 (60.3%)
 Missing 11229 (11.3%)
BMI, kg/m2, mean (SD) 30.0 (7.5)
Rheumatoid arthritis 1252 (1.3%)
Systemic lupus erythematosus 691 (0.7%)
Inflammatory bowel disease 24 (0.1%)
Chronic kidney disease 1601 (1.6%)
Diabetes mellitus 11498 (11.5%)
Asthma 1714 (1.7%)
Chronic obstructive pulmonary disease 2415 (2.4%)
Cancer 302 (0.3%)
HIV/AIDS 673 (0.7%)
Depression 5179 (5.2%)
Use of corticosteroids (including inhaled corticosteroids) 26890 (27.0%)
Use of JAK inhibitors 142 (0.1%)
Received live or adjuvanted, recombinant zoster vaccine 4197 (4.2%)
US region
 Northeast 25865 (25.9%)
 Midwest 32023 (32.1%)
 South 12987 (13.0%)
 West 17714 (17.8%)
 Not reported due to privacy-related suppression 10738 (10.8%)
 NA 359 (0.4%)

Demographic factors were based on self-report. Comorbidities and medications/vaccines were based on electronic health records data.

Perceived stress was not associated with a risk of HZ after adjusting for age, sex, lifestyle factors, comorbidities, and other factors in the multivariable Cox model (adjusted HR for the highest quartile compared to the lowest quartile: 1.00; 95% CI: 0.83-1.19; p for trend = 0.90; Table 2). No association was observed between PSS and risk of HZ when modeled as a continuous variable (adjusted HR 1.00, 95% CI: 0.99–1.01; p = 0.82). We also used restricted cubic splines to model the association between PSS and the risk of HZ; however, we did not observe any non-linear relationship (Supplementary Fig. 2). Social support was not associated with a risk of HZ (adjusted HR for the highest vs. the lowest quartile: 1.09; 95% CI: 0.91-1.31; p for trend = 0.54). When MOS-SS was evaluated as a continuous variable, adjusted HR was 1.00 (95% CI: 0.99-1.01; p = 0.22).

Table 2.

Perceived psychological stress, social support, and risk of herpes zoster.

Quartile 1 Quartile 2 Quartile 3 Quartile 4 p-value for trend
Perceived stress
 Perceived Stress Scale (PSS) 0-7 (low stress) 8-12 13-18 19-40 (high stress)
 HZ cases/person-years 281/57178 247/52822 293/59157 301/61211
 Age-adjusted HR (95% CI) Reference 0.98 (0.83-1.17) 1.08 (0.91-1.27) 1.12 (0.95-1.34) 0.12
 Multivariable-adjusted HR (95% CI) a Reference 0.95 (0.80-1.13) 1.01 (0.86-1.20) 1.00 (0.83-1.19) 0.90
Social support
 Medical Outcomes Study Social Support (MOS-SS) b 0-55 (low support) 56-77 78-95 96-100 (high support)
 HZ cases/person-years 247/52671 266/54495 258/56769 249/51983
 Age-adjusted HR (95% CI) Reference 1.05 (0.88-1.25) 0.98 (0.82-1.17) 1.04 (0.87-1.24) 0.86
 Multivariable-adjusted HR (95% CI)a Reference 1.06 (0.89-1.26) 1.00 (0.83-1.20) 1.09 (0.91-1.31) 0.54

Abbreviation: Hazard Ratio (HR); Confidence Interval (CI); herpes zoster (HZ).

a

Multivariable-adjusted Hazard Ratio (HR) (95% confidence interval [CI]) were based on the multivariable Cox proportional hazards model that include age, sex, race/ethnicity, household income, smoking status, body mass index, cancer, HIV, rheumatoid arthritis, systemic lupus erythematosus, inflammatory bowel disease, chronic kidney disease, diabetes mellitus, asthma, chronic obstructive pulmonary disease, depression, use of corticosteroids, use of JAK inhibitors, and zoster vaccine.

b

Based on 94190 participants responded to all Medical Outcomes Study Social Support questionnaires.

We also performed subgroup analyses. Among participants with low social support (MOS 0-55), those in the highest quartile of perceived stress had a higher risk of developing HZ compared to those in the lowest quartile (adjusted HR for the third quartile: 1.66; 95% CI: 1.03-2.68; and adjuster HR for the highest quartile: 1.65; 95% CI: 1.03–2.66; p for trend = 0.10; Table 3). The association between PSS and risk of HZ based on the restricted cubic splines is shown in the Supplementary Fig. 1. In contrast, among participants with medium or high social support (MOS 56-100), perceived stress was not associated with HZ (adjusted HR for the highest vs. the lowest quartile: 1.01; 95% CI: 0.82-1.26). The association between stress and risk of HZ did not differ by age group, sex, race/ethnicity, and household income (Table 3).

Table 3.

Sub-group analysis of perceived psychological stress and risk of herpes zoster.

Perceived stress scale (PSS)
Quartile 1
0-7 (low)
Quartile 2
8-12
Quartile 3
13-18
Quartile 4
19-40 (high)

Subgroup - Multivariable-adjusted HR (95% CI)a Multivariable-adjusted HR (95% CI)a Multivariable-adjusted HR (95% CI)a p-value for trend
Social supportb
 Low social support Reference 1.58 (0.94-2.65) 1.67 (1.02-2.73) 1.65 (1.01-2.68) 0.14
 Med-high support Reference 0.84 (0.69-1.03) 0.97 (0.80-1.18) 1.01 (0.82-1.25) 0.70
Age category
 < 60 years old Reference 0.80 (0.60-1.09) 0.95 (0.73-1.25) 0.95 (0.73-1.24) 0.81
 ≥ 60 years old Reference 1.04 (0.84-1.28) 1.02 (0.82-1.27) 0.99 (0.77-1.28) 0.97
Sex
 Female Reference 0.91 (0.74-1.13) 0.96 (0.78-1.17) 0.93 (0.75-1.14) 0.59
 Male Reference 1.03 (0.76-1.41) 1.17 (0.86-1.60) 1.18 (0.83-1.68) 0.27
Race/ethnicity
 White Reference 1.00 (0.83-1.20) 0.96 (0.79-1.16) 1.05 (0.86-1.28) 0.71
 Black Reference 1.28 (0.64-2.55) 1.10 (0.56-2.18) 0.63 (0.30-1.33) 0.14
 Hispanic Reference 0.53 (0.23-1.20) 1.31 (0.70-2.44) 0.98 (0.52-1.88) 0.61
Household income
 < 50000 Reference 0.76 (0.54-1.06) 0.79 (0.57-1.08) 0.83 (0.61-1.13) 0.47
 ≥ 50000 Reference 1.09 (0.88-1.34) 1.06 (0.85-1.31) 1.05 (0.83-1.33) 0.73

Abbreviation: Hazard Ratio (HR); Confidence Interval (CI); herpes zoster (HZ); Medical Outcomes Study Social Support (MOS-SS).

Footnote for Table 3.

a

Multivariable-adjusted Hazard Ratio (HR) (95% confidence interval [CI]) were based on the multivariable Cox proportional hazards model that include age, sex, race/ethnicity, household income, smoking status, body mass index, cancer, HIV, rheumatoid arthritis, systemic lupus erythematosus, inflammatory bowel disease, chronic kidney disease, diabetes mellitus, asthma, chronic obstructive pulmonary disease, depression, use of corticosteroids, use of JAK inhibitors, and zoster vaccine.

b

The lowest quartile corresponded to MOS-SS scores below 55, which reflects responses in the lower range of the 5-point Likert scale (i.e., “none of the time,” “a little of the time,” and “some of the time”), indicating low social support. The higher quartiles generally corresponded to responses towards “most of the time” or “all of the time”, indicating moderate to high levels of social support.

In a sensitivity analysis, we restricted the analysis to the first year of follow up. Results remain consistent in the analysis (adjusted HR for the highest quartile to the lowest quartile: 0.86; 95% CI: 0.66-1.13; p-trend p = 0.45).

4. Discussion

Although it is commonly stated in the medical literature that stress is a risk factor for shingles, there is no clear evidence supporting this association. We found no association between perceived psychological stress and the risk of HZ in this large diverse cohort of participants. In the subgroup of participants with low social support, high perceived stress was associated with an increased risk of HZ.

Previous studies have reported conflicting evidence (Table 4). Several case-control studies have reported that recent stressful life events were associated with a higher risk of HZ (Lasserre et al., 2012; Marin et al., 2016; Schmader et al., 1990); however, these studies may be susceptible to recall bias because patients with HZ may be more likely to overreport their prior stress compared to controls. Findings from cohort studies have been inconsistent. A prospective cohort study in the U.S. reported no association between negative life events and risk of HZ (RR 1.20; 95% CI: 0.85-1.67) (Schmader et al., 1998). A large cohort study in Denmark reported that high levels of stress, measured by PSS-10 as in our study, were marginally associated with an increased risk of HZ (adjusted HR for the highest vs. the lowest quintile: 1.14; 95% CI: 0.97-1.34). And a significant elevated risk of HZ was observed in adults with PSS scores ≥30 when using the restricted cubic splines (Schmidt et al., 2021). A cohort study in Japan found that very high levels of perceived stress were associated with a higher risk of HZ in men (adjusted HR 2.22; 95% CI: 1.05-4.66) but not in women (adjusted HR 0.78; 95% CI: 0.37-1.65) (Takao et al., 2018). Additionally, a high sense of purpose in life was associated with a lower risk of HZ in the same cohort from Japan (adjusted HR 0.54; 95% CI: 0.30–0.96). However, several studies have reported that bereavement does not increase the risk of HZ. A self-controlled case series study in the U.S. found no elevated risk of HZ within 90 days following a partner's death or catastrophic health event (IRR 0.76; 95% CI: 0.54–1.06) (Harpaz et al., 2015). Similarly, studies in Denmark and the U.K. reported no elevated risk of HZ following partner bereavement (adjusted OR 1.03; 95% CI: 0.98-1.08) (Schmidt et al., 2017). Prior studies have used various instruments to measure psychological stress, ranging from a single-item measures of daily stress to comprehensive 26-item scales of negative life events, which may have contributed to conflicting results.

Table 4.

Summary of studies examining psychological stress/negative life events and risk of herpes zoster.

Author Study design/population Exposure Adjusted RR/OR
95% (CI)
Adjusted variables
Schmader et al., 1990 A case-control study in the U.S. (101 cases and 101 controls) Negative life events in the last 2 months OR 2.60 (1.13-6.27) Age, sex, and race/ethnicity
Schmader et al., 1998 A prospective cohort study of 4162 adults in the U.S. Negative life events RR 1.20 (0.85-1.67) Age, sex, race, education, chronic diseases, depression
Lasserre et al., 2012 A case-control study in France (250 cases and 500 controls) Negative life events in the last 6 months OR 3.40 (1.67-6.93) Family history, education, comorbidities, depression
Harpaz et al., 2015 A self-controlled case series study of 39811 adults in the U.S. A catastrophic health event or death occurring to a spouse RR 0.76 (0.54-1.06) None (self-controlled)
Marin et al., 2016 A case-control study in the U.S. (389 cases and 511 controls) Severe stress in the last 3 months OR 2.80 (2.06-3.80) Age, sex, family history, vaccination, prior HZ, trauma, depression, and others.
Schmidt et al., 2017 Population-based case-control studies of 190671 adults in Denmark and 150207 adults in the UK Death occurring to a partner OR 1.03 (0.98-1.08) Age, sex, comorbidities, and immunosuppressive conditions/medications
(Takao et al., 2018) A population-based cohort study of 12,359 adults in Japan Perceived mental stress, 1-item, comparing very high to low stress Men: HR 2.22 (1.05-4.66)
Women: HR 0.78 (0.37-1.65)
Age, sex, histories of HZ, cancer, and diabetes, smoking, and drinking habits
Schmidt et al., 2021 A population-based cohort study of 77,310 adults in Denmark Perceived stress scale, 10 items, comparing the highest to the lowest quintile. HR 1.14 (0.97-1.34) Age, sex, chronic conditions, immunosuppressive medications, sociodemographic and lifestyle factors
(Kim and Lee, 2025) Korean Health Panel Survey linked to health records in 78,896 adults Self-rated stress, 5 items, comparing severe to low OR 1.48 (1.16-1.90) Age, sex, education, income, chronic diseases, alcohol, smoking, BMI, physical activity
Current study A cohort study of 99,686 adults in the U.S. Perceived stress scale, 10 items, comparing the highest to the lowest quartile HR 1.00 (0.83-1.19) Age, sex, race/ethnicity, income, smoking, BMI, comorbidities, immunosuppressive medications, and zoster vaccines

We found that high perceived stress was associated with higher risk of HZ among participants with low social support but not among participants with medium to high social support. Consistent with the stress-buffering hypothesis, social support protects against potentially adverse effects of stressful events and may reduce susceptibility to infection (Cohen et al., 2015; Cohen and Wills, 1985). Although cautious interpretation is warranted due to the limited number of patients in this subgroup, the observed association is plausible, as the synergistic effects of high stress and low social support may lead to persistent suppression of VZV-specific cell-mediated immunity; and thus, increasing the risk of HZ.

A limitation of our study is that the PSS measures perceived stress over a brief period. Because stress fluctuates over time, assessing it at a single time point may lead to exposure misclassification, which would most likely attenuate the observed association. Prior research found that approximately half of the variability in repeated PSS assessments over three years reflected between-person differences, despite some within-person variation over time (Harris et al., 2023). PSS has been widely used in longitudinal studies and high perceived stress, often measured only at baseline, has been associated with long-term health outcomes (Prior et al., 2016; Redmond et al., 2013). Nevertheless, repeated assessments of PSS would provide a more accurate assessment of exposure and should be considered in future studies.

Because PSS-10 instrument does not differentiate between acute and chronic stress, we could not determine the effect of chronic stress on HZ. Chronic stress is known to increase the risk of depression (O'Connor et al., 2021), and there is consistent evidence showing the association between depression and an elevated risk of HZ (pooled RR 1.36; 95% CI: 1.15-1.61) (Kawai and Yawn, 2017). McEwen introduced the concept of allostatic load to describe the cumulative dysregulation (“wear and tear”) on the body and brain resulting from repeated or chronic exposure to stress over the life course (McEwen, 1998). While allostatic system allows for stability through changes and adaptation to stressors, chronic stress can lead to persistent activation of the HPA axis, the sympathetic nervous system, and the immune system (O'Connor et al., 2021). Over time, high allostatic load results in dysregulation of neuroendocrine, immunological, metabolic, and cardiovascular systems, thereby increasing the risk of adverse health outcomes. Chronic stress has been associated with an increased risk of developing diabetes mellitus, stroke, myocardial infarction, and other adverse chronic health outcomes (Novak et al., 2013; Osborne et al., 2020; Santosa et al., 2021).

Our study has several strengths and limitations. All of Us Research program is a large cohort study utilizing EHR data from a diverse study population. We adjusted for a wide range of potential confounding factors, including medical conditions, medications/vaccines, and socioeconomic factors. Limitations are also worth noting. The PSS is a self-reported measure of perceived stress and may be subject to reporting bias. As PSS may not have been administered close to the onset of HZ, it may not fully capture the timing and magnitude of stress experienced in the period leading up to the development of HZ. Our study did not evaluate PHN and other complications of HZ. Although All of Us primarily recruits participants through large integrated healthcare systems that capture outpatient and urgent care encounters within their networks, some degree of care fragmentation may occur, potentially resulting in missed HZ diagnoses. Another potential limitation is that the analytic sample represents a subset of the overall All of Us cohort due to survey non-response and availability of eligible EHR data; however, we performed subgroup analyses to assess consistency of findings. The program's strategic oversampling of underrepresented communities may limit the generalizability of the findings to the overall U.S. population; however, it increased the ability to understand the role of stress in HZ by examining subgroup of individuals who may experience disproportionately higher levels of stress.

In conclusion, perceived psychological stress was not associated with the risk of HZ in the overall cohort. However, high perceived stress was associated with an increased risk of HZ among adults with low social support, but not among those with medium to high social support. A highly effective and safe adjuvanted recombinant zoster vaccine is recommended for adults 50 years of age and older to reduce the risk of HZ and its complications.

CRediT authorship contribution statement

Kosuke Kawai: Writing – review & editing, Writing – original draft, Methodology, Investigation, Formal analysis, Conceptualization. Elkin V. Lemos: Writing – review & editing, Methodology, Investigation, Formal analysis, Conceptualization. Barbara P. Yawn: Writing – review & editing, Methodology, Investigation, Conceptualization.

Ethics declaration

Written informed consent to take part in the study and to publish the article has been obtained from all participants or their legal representatives. The privacy rights of participants have been observed.

This study was performed in compliance with relevant laws, regulatory frameworks and guidelines where the research took place. Ethics committee approval was not required under relevant laws and institutional guidelines. The IRB determined that the proposed activity is not research involving human subjects as defined by DHHS and FDA regulations. IRB review and approval is not required.

Financial support

None.

Sources of funding

None.

Declaration of competing interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Acknowledgement

We gratefully acknowledge All of Us participants for their contributions, without whom this research would not have been possible. We also thank the National Institutes of Health's All of Us Research Program.

Footnotes

Appendix A

Supplementary data to this article can be found online at https://doi.org/10.1016/j.bbih.2026.101394.

Appendix A. Supplementary data

The following is the Supplementary data to this article.

Multimedia component 1
mmc1.docx (147.3KB, docx)

Data availability

The authors do not have permission to share data.

References

  1. All of Us Research Program I., Denny J.C., Rutter J.L., Goldstein D.B., Philippakis A., Smoller J.W., Jenkins G., Dishman E. The "All of us" research program. N. Engl. J. Med. 2019;381:668–676. doi: 10.1056/NEJMsr1809937. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cohen S., Janicki-Deverts D., Turner R.B., Doyle W.J. Does hugging provide stress-buffering social support? A study of susceptibility to upper respiratory infection and illness. Psychol. Sci. 2015;26:135–147. doi: 10.1177/0956797614559284. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cohen S., Kamarck T., Mermelstein R. A global measure of perceived stress. J. Health Soc. Behav. 1983;24:385–396. [PubMed] [Google Scholar]
  4. Cohen S., Wills T.A. Stress, social support, and the buffering hypothesis. Psychol. Bull. 1985;98:310–357. [PubMed] [Google Scholar]
  5. Curhan S.G., Kawai K., Yawn B., Rexrode K.M., Rimm E.B., Curhan G.C. Herpes zoster and long-term risk of cardiovascular disease. J. Am. Heart Assoc. 2022;11 doi: 10.1161/JAHA.122.027451. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Ezzati A., Jiang J., Katz M.J., Sliwinski M.J., Zimmerman M.E., Lipton R.B. Validation of the perceived stress scale in a community sample of older adults. Int. J. Geriatr. Psychiatr. 2014;29:645–652. doi: 10.1002/gps.4049. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Forbes H.J., Bhaskaran K., Thomas S.L., Smeeth L., Clayton T., Langan S.M. Quantification of risk factors for herpes zoster: population based case-control study. Br. Med. J. 2014;348 doi: 10.1136/bmj.g2911. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Harpaz R., Leung J.W., Brown C.J., Zhou F.J. Psychological stress as a trigger for herpes zoster: might the conventional wisdom be wrong? Clin. Infect. Dis. 2015;60:781–785. doi: 10.1093/cid/ciu889. [DOI] [PubMed] [Google Scholar]
  9. Harris K.M., Gaffey A.E., Schwartz J.E., Krantz D.S., Burg M.M. The perceived stress scale as a measure of stress: decomposing score variance in longitudinal behavioral medicine studies. Ann. Behav. Med. 2023;57:846–854. doi: 10.1093/abm/kaad015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hope-Simpson R.E. The nature of herpes zoster: a long-term study and a new hypothesis. Proc. Roy. Soc. Med. 1965;58:9–20. doi: 10.1177/003591576505800106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Huang Z., Li X., Lin J., Ding Q., Lu T. Association between depressive symptoms trajectories and Herpes zoster in middle-aged and older adults: a longitudinal national cohort study. J. Psychosom. Res. 2025;196 doi: 10.1016/j.jpsychores.2025.112307. [DOI] [PubMed] [Google Scholar]
  12. Irwin M.R., Levin M.J., Carrillo C., Olmstead R., Lucko A., Lang N., Caulfield M.J., Weinberg A., Chan I.S., Clair J., Smith J.G., Marchese R.D., Williams H.M., Beck D.J., McCook P.T., Johnson G., Oxman M.N. Major depressive disorder and immunity to varicella-zoster virus in the elderly. Brain Behav. Immun. 2011;25:759–766. doi: 10.1016/j.bbi.2011.02.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Janicki Deverts D., Cohen S., Doyle W.J. Dispositional affect moderates the stress-buffering effect of social support on risk for developing the common cold. J. Pers. 2017;85:675–686. doi: 10.1111/jopy.12270. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Johnson R.W., Bouhassira D., Kassianos G., Leplege A., Schmader K.E., Weinke T. The impact of Herpes zoster and post-herpetic neuralgia on quality-of-life. BMC Med. 2010;8:37. doi: 10.1186/1741-7015-8-37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kawai K., Gebremeskel B.G., Acosta C.J. Systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ Open. 2014;4 doi: 10.1136/bmjopen-2014-004833. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kawai K., Yawn B.P. Risk factors for herpes zoster: a systematic review and meta-analysis. Mayo Clin. Proc. 2017;92:1806–1821. doi: 10.1016/j.mayocp.2017.10.009. [DOI] [PubMed] [Google Scholar]
  17. Kim Y., Lee W. Increased risk of Herpes zoster associated with stress and sleep deprivation: evidence from Korea health panel survey. J. Psychiatr. Res. 2025;184:333–339. doi: 10.1016/j.jpsychires.2025.03.015. [DOI] [PubMed] [Google Scholar]
  18. Lal H., Cunningham A.L., Godeaux O., Chlibek R., Diez-Domingo J., Hwang S.J., Levin M.J., McElhaney J.E., Poder A., Puig-Barbera J., Vesikari T., Watanabe D., Weckx L., Zahaf T., Heineman T.C., Group Z.O.E.S. Efficacy of an adjuvanted Herpes zoster subunit vaccine in older adults. N. Engl. J. Med. 2015;372:2087–2096. doi: 10.1056/NEJMoa1501184. [DOI] [PubMed] [Google Scholar]
  19. Lasserre A., Blaizeau F., Gorwood P., Bloch K., Chauvin P., Liard F., Blanchon T., Hanslik T. Herpes zoster: family history and psychological stress-case-control study. J. Clin. Virol. 2012;55:153–157. doi: 10.1016/j.jcv.2012.06.020. [DOI] [PubMed] [Google Scholar]
  20. Marin M., Harpaz R., Zhang J., Wollan P.C., Bialek S.R., Yawn B.P. Risk factors for Herpes zoster among adults. Open Forum Infect. Dis. 2016;3 doi: 10.1093/ofid/ofw119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. McEwen B.S. Protective and damaging effects of stress mediators. N. Engl. J. Med. 1998;338:171–179. doi: 10.1056/NEJM199801153380307. [DOI] [PubMed] [Google Scholar]
  22. McKay S.L., Guo A., Pergam S.A., Dooling K. Herpes zoster risk in immunocompromised adults in the United States: a systematic review. Clin. Infect. Dis. 2020;71:e125–e134. doi: 10.1093/cid/ciz1090. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Moser A., Stuck A.E., Silliman R.A., Ganz P.A., Clough-Gorr K.M. The eight-item modified medical outcomes study social support survey: psychometric evaluation showed excellent performance. J. Clin. Epidemiol. 2012;65:1107–1116. doi: 10.1016/j.jclinepi.2012.04.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Novak M., Bjorck L., Giang K.W., Heden-Stahl C., Wilhelmsen L., Rosengren A. Perceived stress and incidence of type 2 diabetes: a 35-year follow-up study of middle-aged Swedish men. Diabet. Med. 2013;30:e8–e16. doi: 10.1111/dme.12037. [DOI] [PubMed] [Google Scholar]
  25. O'Connor D.B., Thayer J.F., Vedhara K. Stress and health: a review of psychobiological processes. Annu. Rev. Psychol. 2021;72:663–688. doi: 10.1146/annurev-psych-062520-122331. [DOI] [PubMed] [Google Scholar]
  26. Osborne M.T., Shin L.M., Mehta N.N., Pitman R.K., Fayad Z.A., Tawakol A. Disentangling the links between psychosocial stress and cardiovascular disease. Circ., Cardiovasc. Imaging. 2020;13 doi: 10.1161/CIRCIMAGING.120.010931. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Prior A., Fenger-Gron M., Larsen K.K., Larsen F.B., Robinson K.M., Nielsen M.G., Christensen K.S., Mercer S.W., Vestergaard M. The association between perceived stress and mortality among people with multimorbidity: a prospective population-based cohort study. Am. J. Epidemiol. 2016;184:199–210. doi: 10.1093/aje/kwv324. [DOI] [PubMed] [Google Scholar]
  28. Qian J., Banks E., Macartney K., Heywood A.E., Lassere M.N., Liu B. Corticosteroid use and risk of Herpes zoster in a population-based cohort. Mayo Clin. Proc. 2021;96:2843–2853. doi: 10.1016/j.mayocp.2021.05.029. [DOI] [PubMed] [Google Scholar]
  29. Redmond N., Richman J., Gamboa C.M., Albert M.A., Sims M., Durant R.W., Glasser S.P., Safford M.M. Perceived stress is associated with incident coronary heart disease and all-cause mortality in low- but not high-income participants in the reasons for geographic and racial differences in stroke study. J. Am. Heart Assoc. 2013;2 doi: 10.1161/JAHA.113.000447. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Roy V., Ruel S., Ivers H., Savard M.H., Gouin J.P., Caplette-Gingras A., Lemieux J., Couture F., Savard J. Stress-buffering effect of social support on immunity and infectious risk during chemotherapy for breast cancer. Brain Behav Immun Health. 2021;10 doi: 10.1016/j.bbih.2020.100186. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Santosa A., Rosengren A., Ramasundarahettige C., Rangarajan S., Gulec S., Chifamba J., Lear S.A., Poirier P., Yeates K.E., Yusuf R., Orlandini A., Weida L., Sidong L., Yibing Z., Mohan V., Kaur M., Zatonska K., Ismail N., Lopez-Jaramillo P., Iqbal R., Palileo-Villanueva L.M., Yusufali A.H., AlHabib K.F., Yusuf S. Psychosocial risk factors and cardiovascular disease and death in a population-based cohort from 21 Low-, Middle-, and high-income countries. JAMA Netw. Open. 2021;4 doi: 10.1001/jamanetworkopen.2021.38920. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Schmader K., George L.K., Burchett B.M., Pieper C.F. Racial and psychosocial risk factors for Herpes zoster in the elderly. J. Infect. Dis. 1998;178(Suppl. 1):S67–S70. doi: 10.1086/514254. [DOI] [PubMed] [Google Scholar]
  33. Schmader K., Studenski S., MacMillan J., Grufferman S., Cohen H.J. Are stressful life events risk factors for herpes zoster? J. Am. Geriatr. Soc. 1990;38:1188–1194. doi: 10.1111/j.1532-5415.1990.tb01497.x. [DOI] [PubMed] [Google Scholar]
  34. Schmidt S.A., Vestergaard M., Pedersen H.S., Schonheyder H.C., Thomas S.L., Smeeth L., Mansfield K.E., Sorensen H.T., Forbes H.J., Langan S.M. Partner bereavement and risk of herpes zoster: results from two population-based case-control studies in Denmark and the United Kingdom. Clin. Infect. Dis. 2017;64:572–579. doi: 10.1093/cid/ciw840. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Schmidt S.A.J., Sorensen H.T., Langan S.M., Vestergaard M. Perceived psychological stress and risk of herpes zoster: a nationwide population-based cohort study. Br. J. Dermatol. 2021;185:130–138. doi: 10.1111/bjd.19832. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Sinayobye J., Hoover D.R., Shi Q., Mutimura E., Cohen H.W., Anastos K. Prevalence of shingles and its association with PTSD among HIV-Infected women in Rwanda. BMJ Open. 2015;5 doi: 10.1136/bmjopen-2014-005506. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Takao Y., Okuno Y., Mori Y., Asada H., Yamanishi K., Iso H. Associations of perceived mental stress, sense of purpose in life, and negative life events with the risk of incident Herpes zoster and postherpetic neuralgia: the SHEZ study. Am. J. Epidemiol. 2018;187:251–259. doi: 10.1093/aje/kwx249. [DOI] [PubMed] [Google Scholar]
  38. Winthrop K.L., Nash P., Yamaoka K., Mysler E., Khan N., Camp H.S., Song Y., Suboticki J.L., Curtis J.R. Incidence and risk factors for Herpes zoster in patients with rheumatoid arthritis receiving upadacitinib: a pooled analysis of six phase III clinical trials. Ann. Rheum. Dis. 2022;81:206–213. doi: 10.1136/annrheumdis-2021-220822. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Yawn B.P., Callen E., Gaona-Villarreal G., Shaikh A., Pace W.D. Increased Herpes zoster risk with inhaled corticosteroid use for those with chronic obstructive pulmonary disease. Chronic Obstr Pulm Dis. 2024;11:303–306. doi: 10.15326/jcopdf.2023.0478. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Yawn B.P., Saddier P., Wollan P.C., St Sauver J.L., Kurland M.J., Sy L.S. A population-based study of the incidence and complication rates of Herpes zoster before zoster vaccine introduction. Mayo Clin. Proc. 2007;82:1341–1349. doi: 10.4065/82.11.1341. [DOI] [PubMed] [Google Scholar]
  41. Yawn B.P., Wollan P.C., Nagel M.A., Gilden D. Risk of stroke and myocardial infarction after Herpes zoster in older adults in a US community population. Mayo Clin. Proc. 2016;91:33–44. doi: 10.1016/j.mayocp.2015.09.015. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Multimedia component 1
mmc1.docx (147.3KB, docx)

Data Availability Statement

The authors do not have permission to share data.


Articles from Brain, Behavior, & Immunity - Health are provided here courtesy of Elsevier

RESOURCES